BIOMAT Database Logo BIOMAT Database Logo

Letter: Low molecular weight dextran therapy. 1975

S A Johnson, and D D Parnell

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D003911 Dextrans A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Dextran,Dextran 40,Dextran 40000,Dextran 70,Dextran 75,Dextran 80,Dextran B-1355,Dextran B-1355-S,Dextran B1355,Dextran B512,Dextran Derivatives,Dextran M 70,Dextran T 70,Dextran T-40,Dextran T-500,Hemodex,Hyskon,Infukoll,Macrodex,Polyglucin,Promit,Rheodextran,Rheoisodex,Rheomacrodex,Rheopolyglucin,Rondex,Saviosol,Dextran B 1355,Dextran B 1355 S,Dextran T 40,Dextran T 500
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

S A Johnson, and D D Parnell
Low molecular weight dextran.
September 1967, The Medical clinics of North America,
S A Johnson, and D D Parnell
LOW MOLECULAR WEIGHT DEXTRAN.
July 1964, Nutrition reviews,
S A Johnson, and D D Parnell
LOW-MOLECULAR-WEIGHT DEXTRAN.
July 1964, Lancet (London, England),
S A Johnson, and D D Parnell
Low molecular weight dextran.
January 2001, Indian journal of dermatology, venereology and leprology,
S A Johnson, and D D Parnell
Low molecular weight dextran.
January 1977, British medical journal,
S A Johnson, and D D Parnell
[Low-weight molecular dextran].
January 1970, Coeur et medecine interne,
S A Johnson, and D D Parnell
LOW-MOLECULAR-WEIGHT DEXTRAN.
May 1964, Lancet (London, England),
S A Johnson, and D D Parnell
LOW-MOLECULAR-WEIGHT DEXTRAN THERAPY IN EXPERIMENTAL PANCREATITIS.
May 1965, JAMA,
S A Johnson, and D D Parnell
LOW MOLECULAR WEIGHT DEXTRAN THERAPY IN SURGICAL SHOCK. 1. CONTROL GROUP AND SHOCK PATIENTS RESUSCITATED PRIOR TO LOW MOLECULAR WEIGHT DEXTRAN THERAPY.
August 1964, Archives of surgery (Chicago, Ill. : 1960),
S A Johnson, and D D Parnell
Low molecular weight dextran infusions.
April 1971, British medical journal,
Copied contents to your clipboard!